\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes Digital, Industry & SpaceNGI Sargasso, an EU project funding collaboration between EU and USA/Canada organisations on emerging Internet technologies just launched its 2nd Open Call.
The NGI Sargasso call will be open until 18 December 2023, and it will grant the EU beneficiaries up to €100,000 and a tailored support programme.
Beneficiaries of this Open Call can be:
The mission of the program is to set up Transatlantic Teams (one organisation from Europe + another from the USA/Canada) to work on short-term projects (3-9 months) labeled as Next Generation Internet.
Projects should be
In case of interest, please visit the project website and make use of the brokerage platform that helps potential applicants to find partners in the USA or Canada.
Also, the project will hold an info webinar and matchmaking event on 20 November 2023.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
